Rajat Bannerji, MD, PhD

Resident Member, Rutgers Cancer Institute of New Jersey

Associate* Member, Clinical Investigations and Precision Therapeutics Program

Member since 2012

Academic Appointment

Professor
Division of Hematology Oncology
Department of Medicine
Robert Wood Johnson Medical School
Rutgers, The State University of New Jersey

Positions

• Chief, Section of Hematologic Malignancies at Rutgers Cancer Institute of New Jersey

Links

• Physician Profile
• Research with Rutgers Profile

Research Interests

• Development of novel therapeutics for hematologic malignancies
• Therapy for high risk, relapsed and refractory chronic lymphocytic leukemia (CLL)
• Translational studies in CLL to develop biomarkers for treatment response

Selected Publications